Da-Yong Lu* and Jin-Yu Che

School of Life Sciences, Shanghai University, Shanghai, China

*Corresponding Author: Da-Yong Lu, School of Life Sciences, Shanghai University, Shanghai, China.

Received: August 25, 2021; Published: October 01, 2021

Abstract

Osteoporosis is an issue of public health concern worldwide. Currently, it is very difficult in the clinic. To face with this difficulty, the therapeutic breakthrough is a top priority. This editorial aims to discuss this hot topic of orthopedic disease.

Keywords: Osteoporosis; Clinical Trial; Personalized Medicine; Orthopedic Disease

References

1. Melton J. “Hip fracture; a worldwide problem today and tomorrow”. Bone 14 (1993): S1-8.
2. Lu DY and Che JY. “Osteoporosis treatments”. Clinical Biotechnology and Macrobiology2 (2019): 612-614.
3. Lu DY., et al. “Osteoporosis in old women, therapeutic selection”. EC Orthopaedics7 (2018): 386.
4. Choudhary D and Alam A. “Anti-osteoporotic activity of bioactive compounds from Iris germanica targeting NK-Kappa B”. EC Pharmacology and Toxicology8 (2018): 665-678.
5. Marks R. “Vitamin E and osteoarthritic cartilage: Does vitamin E influence cartilage integrity?” EC Orthopaedics5 (2019): 281-294.
6. Patel S. “Conservative pain management”. EC Orthopaedics8 (2018): 621-623.
7. Lu DY., et al. “Osteoporosis, importance for early diagnosis and treatment”. EC Orthopaedics9 (2018): 624-625.
8. Lu DY., et al. “Osteoporosis treatments for old people”. EC Orthopeadicis5 (2019): 278-280.
9. Lu DY., et al. “Bone disease recovery strategies, An overview”. EC Orthopaedics1 (2019): 1-3.
10. Araujo JL. “The role of the orthopedic surgeon in preventing low back pain chronification”. EC Orthopaedics 12 (2018): 809-812.
11. Harsini SM and Oryan A. “Bone grafting and the materials for using in orthopaedics”. EC Orthopaedics 12 (2018): 822-833.
12. Zweedijk R., et al. “Scoliosis and osteopathy”. Acta Scientific Orthopaedics 9 (2020): 30-43.
13. Lu DY and Che JY. “Bone disease treatment, an editorial”. EC Orthopeadics 8 (2020): 143-145.
14. Lu DY., et al. “Bone disease recovery strategies, An overview”. EC Orthopaedics 1 (2019): 1-3.
15. Koleva IB and Yoshinov B. “Rehabilitation as an essential element in the clinical practice of orthopaedics and traumatology”. Acta Scientific Orthopaedics 9 (2020): 44-46.
16. Lu DY., et al. “Osteoporosis treatments for old people”. EC Orthopeadicis 5 (2019): 278-280.
17. Che JY and Lu DY. “Bone disease treatment, future direction”. EC Pharmacology and Toxicology 1 (2021): 7-8.
18. Negm SH. “The possible protective role of powder cuttlefish bone, crab shell and eggshell on osteoporotic rats”. Journal of Food and Dairy Sciences10 (2018): 111-121.
19. Mobasheri A and Shakbael M. “Osteogenic effects of resveratrol in vitro: potential for the prevention and treatment of osteoporosis”. Annals of the New York Academy of Sciences 1290 (2013): 59-66.
20. Madrv H., et al. “Scaffold-mediated gene delivery for osteochondral repair”. Pharmaceutics 12 (2020): 930.
21. Lu DY and Che JY. “Bone disease treatments, technical advances”. EC Orthopeadics10 (2020): 1-3.
22. Lu DY., et al. “Bone disease treatments, math-therapeutic modality”. EC Orthopaedics3 (2019): 140-143.
23. Lu DY and Lu TR. “Drug discoveries from natural resources”. Journal of Primary Care and General Practice1 (2019): 28.
24. Muthuraman A., et al. “Integration of artificial intelligence in pharmacological research with deep and machine learning process”. EC Pharmacology and Toxicology11 (2019): 56-61.
25. Freedman DH. “Hunting for new drugs with AI”. Nature 576 (2019): s49-s53.
26. Borrego-Gonzalez S., et al. “Sponge-like processed D-periodic self-assembled atelocollagen supports bone formation in vivo”. Materials Science and Engineering C (2020).
27. Leung PC. “Traditional Chinese medicine in orthopaedics—problems and future direction”. Open Journal of Therapy and Rehabilitation1 (2014): 1-4.
28. Lu DY. “Personalized cancer chemotherapy, an effective way for enhancing outcomes in clinics. 2014, Woodhead Publishing, Elsevier, UK (2014).
29. Lu DY., et al. “Individualized cancer therapy, future approaches”. Current Pharmacogenomics and Personalized Medicine2 (2018): 156-163.
30. Lu DY., et al. “HAART in HIV/AIDS treatments, future trends”. Infectious Disorders-Drug Targets 1 (2018): 15-22.
31. Lu DY., et al. “HIV/AIDS curable study, new forms of therapeutic trinity”. Recent Patents on Anti-Infective Drug Discovery 3 (2018): 217-227.
32. Lu DY., et al. “Anticancer drug combination, how far we can go through?” Anti-Cancer Agents in Medicinal Chemistry 1 (2017): 21-28.
33. Lu DY., et al. “Drug combination in clinical cancer treatment”. Reviews on Recent Clinical Trials 3 (2017): 202-211.
34. Lu DY., et al. “Individualized cancer therapy, what is the next generation?” EC Cancer 6 (2018): 286-297.

Citation

Citation: Da-Yong Lu and Jin-Yu Che. “Osteoporosis Targeting, Possible Breakthroughs".Acta Scientific Orthopaedics 4.11 (2021): 01-03.

Copyright

Copyright: © 2021 Da-Yong Lu and Jin-Yu Che. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.